Multivalent Antibody-Recruiting Macromolecules: Linking Increased Binding Affinity with Enhanced Innate Immune...

Area of Science:

• Immunology
• Biotechnology
• Drug Discovery

Background:

• Antibody-recruiting molecules (ARMs) are emerging immunotherapeutics.
• ARMs direct antibodies to disease targets like cancer cells, bacteria, or viruses.
• This triggers immune responses such as ADCC, CDC, and ADCP to eliminate pathogens.

Purpose of the Study:

• To review the current status of multivalent ARMs.
• To explore the benefits of multivalent ARMs over classic ARMs.
• To discuss challenges and future directions for multivalent ARM development.

Main Methods:

• Minireview of existing literature on multivalent ARMs.
• Analysis of structural components: target-binding termini (TBT) and antibody-binding termini (ABT).
• Evaluation of multivalent interactions and their impact on binding avidity.

Main Results:

• Multivalent ARMs offer increased efficiency in antibody recruitment and immune cell activation.
• Multiple target-binding and antibody-binding termini enhance binding avidity.
• Multivalency converts low-affinity interactions into strong, effective binding.

Conclusions:

• Multivalent ARMs represent a promising advancement in immunotherapeutics.
• They hold potential for enhanced efficacy in treating various diseases.
• Further research is needed to overcome development hurdles and realize their full therapeutic potential.